Literature DB >> 19054294

The population prevalence of adverse concentrations and associations with adiposity of liver tests among Australian adolescents.

Michael L Booth1, Jacob George, Elizabeth Denney-Wilson, Anthony D Okely, Louise L Hardy, Robert Aitken, Tim Dobbins.   

Abstract

AIM: Paediatric overweight has a high incidence and has serious consequences for health, including non-alcoholic fatty liver disease (NAFLD). However, very little is known about NAFLD among young people, particularly from a population perspective. This paper reports the prevalence of elevated concentrations of four liver enzymes and their associations with adiposity in a representative population sample of Australian adolescents.
METHODS: Overnight fasting blood samples were collected from a representative population sample of 500 Grade 10 students (15-years-old) attending schools in Sydney, Australia, between February and May, 2004. Weight, height and waist girth were measured. The prevalence of adverse concentrations of the enzymes alanine aminotransferase (ALT), gamma-glutamyltransferase (GGT), aspartate aminotransferase (AST) and alkaline phosphatase (ALP) were described for all boys and girls and by body mass index (BMI) categories. The nature of the associations between the enzyme concentrations and indices of adiposity were characterised, and regression equations for estimating enzyme concentrations from BMI were prepared.
RESULTS: The prevalence of adverse concentrations of ALT (most likely as a result of NAFLD) and GGT were approximately 10%, while the prevalence of adverse concentrations of AST and ALP were approximately 7% and 5% respectively. The prevalence of adverse concentrations of ALT, GGT and AST increased across BMI categories, while the prevalence of adverse concentrations of ALP declined across BMI categories.
CONCLUSIONS: The high prevalence of NAFLD in a population sample of healthy Australian adolescents represents a significant burden of disease.

Entities:  

Mesh:

Year:  2008        PMID: 19054294     DOI: 10.1111/j.1440-1754.2008.01407.x

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN: 1034-4810            Impact factor:   1.954


  7 in total

1.  Overview of screening methods for fatty liver disease in children.

Authors:  Caroline Anitha Devadason; Ann O Scheimann
Journal:  World J Hepatol       Date:  2012-01-27

2.  Alkaline phosphatase and percentage body fat predict circulating C-reactive protein in premenopausal women.

Authors:  Fatima Nayeem; Karl E Anderson; Manubai Nagamani; James J Grady; Lee-Jane W Lu
Journal:  Biomarkers       Date:  2010-09-29       Impact factor: 2.658

Review 3.  Childhood obesity and its physical and psychological co-morbidities: a systematic review of Australian children and adolescents.

Authors:  Ross H Sanders; Ahreum Han; Julien S Baker; Stephen Cobley
Journal:  Eur J Pediatr       Date:  2015-04-29       Impact factor: 3.183

Review 4.  NAFLD in children: new genes, new diagnostic modalities and new drugs.

Authors:  Valerio Nobili; Anna Alisi; Luca Valenti; Luca Miele; Ariel E Feldstein; Naim Alkhouri
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-07-05       Impact factor: 46.802

5.  The effect of liver enzymes on adiposity: a Mendelian randomization study.

Authors:  Junxi Liu; Shiu Lun Au Yeung; Man Ki Kwok; June Yue Yan Leung; Shi Lin Lin; Lai Ling Hui; Gabriel Matthew Leung; C Mary Schooling
Journal:  Sci Rep       Date:  2019-11-14       Impact factor: 4.379

6.  The effect of liver enzymes on body composition: A Mendelian randomization study.

Authors:  Junxi Liu; Shiu Lun Au Yeung; Man Ki Kwok; June Yue Yan Leung; Lai Ling Hui; Gabriel Matthew Leung; C Mary Schooling
Journal:  PLoS One       Date:  2020-02-11       Impact factor: 3.240

7.  A Nomogram for Predicting Non-Alcoholic Fatty Liver Disease in Obese Children.

Authors:  Ahlee Kim; Hye Ran Yang; Jin Min Cho; Ju Young Chang; Jin Soo Moon; Jae Sung Ko
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2020-05-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.